Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schulman

Showing results (1-10 of 424) with videos related to

Pageof 43
Sort By:
Journal of Internal Medicine|September 17, 2003
Novel anticoagulant agents: introductionS Schulman
Wiener Medizinische Wochenschrift (1946)|June 23, 1999
The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study GroupS Schulman
Haemostasis|January 12, 2000
For how long should the treatment with vitamin K antagonists be maintained?S Schulman
Seminars in Thrombosis and Hemostasis|November 25, 2000
Continuous infusion of recombinant factor VIIa in hemophilic patients with inhibitors: safety, monitoring, and cost effectivenessS Schulman,
Lakartidningen|January 25, 1989
[Elimination of antibodies against coagulation factor VIII: Factor VIIa is the most promising therapeutic alternative]S Schulman
Journal of Neuropathology and Experimental Neurology|January 1, 1972
In memoriam: Richard Biddle Richter May 9, 1901-April 6, 1971S Schulman
Journal of Internal Medicine|August 1, 1994
Quality of oral anticoagulant control and treatment in Sweden. Duration of Anticoagulation (DURAC) Trial Study GroupS Schulman
Journal of Internal Medicine|February 28, 2001
Study patients and routine practice patientsS Schulman
Lakartidningen|December 7, 2000
[Venous thromboembolism, warfarin and cancer--a well-known connection]S Schulman
Transactions of the American Neurological Association|January 1, 1973
Impaired tool-using behavior in monkeys from bilateral destruction of the dorsomedial nuclei of the thalamusS Schulman
Pageof 43

Showing results (1-10 of 424) with videos related to

Sort By:
Pageof 43
Journal of Internal Medicine|September 17, 2003
Novel anticoagulant agents: introductionS Schulman
Wiener Medizinische Wochenschrift (1946)|June 23, 1999
The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study GroupS Schulman
Haemostasis|January 12, 2000
For how long should the treatment with vitamin K antagonists be maintained?S Schulman
Seminars in Thrombosis and Hemostasis|November 25, 2000
Continuous infusion of recombinant factor VIIa in hemophilic patients with inhibitors: safety, monitoring, and cost effectivenessS Schulman,
Lakartidningen|January 25, 1989
[Elimination of antibodies against coagulation factor VIII: Factor VIIa is the most promising therapeutic alternative]S Schulman
Journal of Neuropathology and Experimental Neurology|January 1, 1972
In memoriam: Richard Biddle Richter May 9, 1901-April 6, 1971S Schulman
Journal of Internal Medicine|August 1, 1994
Quality of oral anticoagulant control and treatment in Sweden. Duration of Anticoagulation (DURAC) Trial Study GroupS Schulman
Journal of Internal Medicine|February 28, 2001
Study patients and routine practice patientsS Schulman
Lakartidningen|December 7, 2000
[Venous thromboembolism, warfarin and cancer--a well-known connection]S Schulman
Transactions of the American Neurological Association|January 1, 1973
Impaired tool-using behavior in monkeys from bilateral destruction of the dorsomedial nuclei of the thalamusS Schulman
Pageof 43